Selected research
Industry Research
Bifidus Industry Research Report 2026
Market perspective
The global Bifidus market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Bifidus is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Bifidus is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Bifidus is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Bifidus include Chr-Hansen, DuPont, Wecare Probiotics, Probi, Mitushi Bio Pharma, Scitop Bio-tech, Lallemand, Goerlich Pharma and Shandong Zhongke Jiayi Bioengineering, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Bifidus market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Bifidus Market by Company
Chr-Hansen
DuPont
Wecare Probiotics
Probi
Mitushi Bio Pharma
Scitop Bio-tech
Lallemand
Goerlich Pharma
Shandong Zhongke Jiayi Bioengineering
Danone
Shanghai SPH Sinopharm
Bifidus Segment by Type
Food Grade
Pharmaceutical Grade
Bifidus Segment by Application
Food & Beverages
Medicines
Health Products
Others
Bifidus Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bifidus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Bifidus and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bifidus.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Bifidus manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Bifidus by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Bifidus in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Food Grade
- Pharmaceutical Grade
Applications
- Food & Beverages
- Medicines
- Health Products
- Others
Companies covered
- Chr-Hansen
- DuPont
- Wecare Probiotics
- Probi
- Mitushi Bio Pharma
- Scitop Bio-tech
- Lallemand
- Goerlich Pharma
- Shandong Zhongke Jiayi Bioengineering
- Danone
- Shanghai SPH Sinopharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Bifidus Market Size (2021-2032)
- 2.2.2 Global Bifidus Sales (2021-2032)
- 2.2.3 Global Bifidus Market Average Price (2021-2032)
- 2.3 Bifidus by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Food Grade
- 2.3.3 Pharmaceutical Grade
- 2.4 Bifidus by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Food & Beverages
- 2.4.3 Medicines
- 2.4.4 Health Products
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Bifidus Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Bifidus Sales (k units) of Manufacturers (2021-2026)
- 3.3 Global Bifidus Revenue of Manufacturers (2021-2026)
- 3.4 Global Bifidus Average Price by Manufacturers (2021-2026)
- 3.5 Global Bifidus Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Bifidus, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Bifidus, Product Type & Application
- 3.8 Global Manufacturers of Bifidus, Established Date
- 3.9 Global Bifidus Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chr-Hansen
- 4.1.1 Chr-Hansen Company Information
- 4.1.2 Chr-Hansen Business Overview
- 4.1.3 Chr-Hansen Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chr-Hansen Bifidus Product Portfolio
- 4.1.5 Chr-Hansen Recent Developments
- 4.2 DuPont
- 4.2.1 DuPont Company Information
- 4.2.2 DuPont Business Overview
- 4.2.3 DuPont Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 DuPont Bifidus Product Portfolio
- 4.2.5 DuPont Recent Developments
- 4.3 Wecare Probiotics
- 4.3.1 Wecare Probiotics Company Information
- 4.3.2 Wecare Probiotics Business Overview
- 4.3.3 Wecare Probiotics Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Wecare Probiotics Bifidus Product Portfolio
- 4.3.5 Wecare Probiotics Recent Developments
- 4.4 Probi
- 4.4.1 Probi Company Information
- 4.4.2 Probi Business Overview
- 4.4.3 Probi Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Probi Bifidus Product Portfolio
- 4.4.5 Probi Recent Developments
- 4.5 Mitushi Bio Pharma
- 4.5.1 Mitushi Bio Pharma Company Information
- 4.5.2 Mitushi Bio Pharma Business Overview
- 4.5.3 Mitushi Bio Pharma Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mitushi Bio Pharma Bifidus Product Portfolio
- 4.5.5 Mitushi Bio Pharma Recent Developments
- 4.6 Scitop Bio-tech
- 4.6.1 Scitop Bio-tech Company Information
- 4.6.2 Scitop Bio-tech Business Overview
- 4.6.3 Scitop Bio-tech Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Scitop Bio-tech Bifidus Product Portfolio
- 4.6.5 Scitop Bio-tech Recent Developments
- 4.7 Lallemand
- 4.7.1 Lallemand Company Information
- 4.7.2 Lallemand Business Overview
- 4.7.3 Lallemand Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Lallemand Bifidus Product Portfolio
- 4.7.5 Lallemand Recent Developments
- 4.8 Goerlich Pharma
- 4.8.1 Goerlich Pharma Company Information
- 4.8.2 Goerlich Pharma Business Overview
- 4.8.3 Goerlich Pharma Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Goerlich Pharma Bifidus Product Portfolio
- 4.8.5 Goerlich Pharma Recent Developments
- 4.9 Shandong Zhongke Jiayi Bioengineering
- 4.9.1 Shandong Zhongke Jiayi Bioengineering Company Information
- 4.9.2 Shandong Zhongke Jiayi Bioengineering Business Overview
- 4.9.3 Shandong Zhongke Jiayi Bioengineering Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Shandong Zhongke Jiayi Bioengineering Bifidus Product Portfolio
- 4.9.5 Shandong Zhongke Jiayi Bioengineering Recent Developments
- 4.10 Danone
- 4.10.1 Danone Company Information
- 4.10.2 Danone Business Overview
- 4.10.3 Danone Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Danone Bifidus Product Portfolio
- 4.10.5 Danone Recent Developments
- 4.11 Shanghai SPH Sinopharm
- 4.11.1 Shanghai SPH Sinopharm Company Information
- 4.11.2 Shanghai SPH Sinopharm Business Overview
- 4.11.3 Shanghai SPH Sinopharm Bifidus Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Shanghai SPH Sinopharm Bifidus Product Portfolio
- 4.11.5 Shanghai SPH Sinopharm Recent Developments
5 Global Bifidus Market Scenario by Region
- 5.1 Global Bifidus Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Bifidus Sales by Region: 2021-2032
- 5.2.1 Global Bifidus Sales by Region: 2021-2026
- 5.2.2 Global Bifidus Sales by Region: 2027-2032
- 5.3 Global Bifidus Revenue by Region: 2021-2032
- 5.3.1 Global Bifidus Revenue by Region: 2021-2026
- 5.3.2 Global Bifidus Revenue by Region: 2027-2032
- 5.4 North America Bifidus Market Facts & Figures by Country
- 5.4.1 North America Bifidus Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Bifidus Sales by Country (2021-2032)
- 5.4.3 North America Bifidus Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Bifidus Market Facts & Figures by Country
- 5.5.1 Europe Bifidus Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Bifidus Sales by Country (2021-2032)
- 5.5.3 Europe Bifidus Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Bifidus Market Facts & Figures by Country
- 5.6.1 Asia Pacific Bifidus Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Bifidus Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Bifidus Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Bifidus Market Facts & Figures by Country
- 5.7.1 South America Bifidus Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Bifidus Sales by Country (2021-2032)
- 5.7.3 South America Bifidus Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Bifidus Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Bifidus Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Bifidus Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Bifidus Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Bifidus Sales by Type (2021-2032)
- 6.1.1 Global Bifidus Sales by Type (2021-2032) & (k units)
- 6.1.2 Global Bifidus Sales Market Share by Type (2021-2032)
- 6.2 Global Bifidus Revenue by Type (2021-2032)
- 6.2.1 Global Bifidus Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Bifidus Revenue Market Share by Type (2021-2032)
- 6.3 Global Bifidus Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Bifidus Sales by Application (2021-2032)
- 7.1.1 Global Bifidus Sales by Application (2021-2032) & (k units)
- 7.1.2 Global Bifidus Sales Market Share by Application (2021-2032)
- 7.2 Global Bifidus Revenue by Application (2021-2032)
- 7.2.1 Global Bifidus Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Bifidus Revenue Market Share by Application (2021-2032)
- 7.3 Global Bifidus Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Bifidus Value Chain Analysis
- 8.1.1 Bifidus Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Bifidus Production Mode & Process
- 8.2 Bifidus Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Bifidus Distributors
- 8.2.3 Bifidus Customers
9 Global Bifidus Analyzing Market Dynamics
- 9.1 Bifidus Industry Trends
- 9.2 Bifidus Industry Drivers
- 9.3 Bifidus Industry Opportunities and Challenges
- 9.4 Bifidus Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst